Vaccine facility to be operational by the end of the year


Sinovac Biotech’s SA partner plans to have a vaccine-making facility operational by the end of the year, after the two companies started a Covid-19 inoculation trial in infants, children and adolescents, reported Business Day (16 September 2021).
Numolux Group expects the so-called fill-and-finish factory to produce 100-m doses a year once it’s operating at full capacity. “The long-term plan is the manufacture and distribution of vaccines on the continent of Africa.”


Other news